» Articles » PMID: 34929030

Mycobacterium Tuberculosis-Specific T-Cell Responses Are Impaired During Late Pregnancy With Elevated Biomarkers of Tuberculosis Risk Postpartum

Abstract

Background: Pregnancy is a risk factor for progression from latent tuberculosis infection to symptomatic tuberculosis. However, how pregnancy influences T-cell responses to Mycobacterium tuberculosis is unknown.

Methods: We measured M. tuberculosis-specific cytokines, T-cell memory markers, and overall CD4+ and CD8+ T-cell activation by flow cytometry from 49 women (18 with and 31 without HIV) who became pregnant while enrolled in a randomized controlled trial of preexposure prophylaxis for HIV. We analyzed data using COMPASS, an established statistical method for evaluating overall antigen-specific T-cell responses.

Results: Pregnant women with latent tuberculosis infection demonstrated significantly diminished M. tuberculosis-specific CD4+ cytokine responses in the third trimester (COMPASS polyfunctional score [PFS], 0.07) compared before (PFS, 0.15), during (PFS, 0.13 and 0.16), and after pregnancy (PFS, 0.14; P = .0084, Kruskal-Wallis test). Paradoxically, M. tuberculosis-specific CD8+ cytokines and nonspecifically activated T-cells increased during late pregnancy. Nonspecific T-cell activation, a validated biomarker for progression from latent tuberculosis infection to tuberculosis disease, increased in latent tuberculosis infection-positive women postpartum, compared with latent tuberculosis infection-negative women.

Conclusions: Pregnancy-related functional T-cell changes were most pronounced during late pregnancy. Both M. tuberculosis-specific T-cell changes during pregnancy and increases in immune activation postpartum may contribute to increased risk for tuberculosis progression.

Clinical Trials Registration: NCT0557245.

Citing Articles

Immune-neuroendocrine reactivity and features of tuberculosis in pregnancy.

Starshinova A, Churilov L, Kudryavtsev I, Rubinstein A, Belyaeva E, Kulpina A Front Med (Lausanne). 2025; 12:1503402.

PMID: 39981081 PMC: 11840263. DOI: 10.3389/fmed.2025.1503402.


Diminished -specific T-cell Responses During Pregnancy in Women With HIV and Receiving Isoniazid Preventive Therapy.

Saha A, Escudero J, Layouni T, Mecha J, Maleche-Obimbo E, Matemo D Open Forum Infect Dis. 2025; 12(2):ofaf067.

PMID: 39981072 PMC: 11842132. DOI: 10.1093/ofid/ofaf067.


Discordance of 3rd and 4th generation QuantiFERON-TB Gold assays by pregnancy stages in India.

Kulkarni V, Alexander M, Bhosale R, Jain D, Deshpande P, Gitlin E J Clin Tuberc Other Mycobact Dis. 2025; 38:100504.

PMID: 39758562 PMC: 11697401. DOI: 10.1016/j.jctube.2024.100504.


Tuberculosis Caused by Isoniazid-Resistant Strain Was Transmitted from a Woman Undergoing IVFET to Her Fetus by Intrauterine: A Case Report.

Li S, Wang J, Yu H, Huang H, Lu S, Wang X Infect Drug Resist. 2024; 17:5463-5468.

PMID: 39711830 PMC: 11663480. DOI: 10.2147/IDR.S478844.


The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya.

Quincer E, Lyland A, Onyango D, LaCourse S, Figueroa J, John-Stewart G Int J Tuberc Lung Dis. 2023; 27(12):906-911.

PMID: 38042967 PMC: 11057228. DOI: 10.5588/ijtld.23.0134.


References
1.
Mathad J, Gupta A . Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis. 2012; 55(11):1532-49. PMC: 3491857. DOI: 10.1093/cid/cis732. View

2.
Leveton C, Barnass S, Champion B, Lucas S, de Souza B, Nicol M . T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect Immun. 1989; 57(2):390-5. PMC: 313109. DOI: 10.1128/iai.57.2.390-395.1989. View

3.
Lewinsohn D, Tydeman I, Frieder M, Grotzke J, Lines R, Ahmed S . High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. Microbes Infect. 2006; 8(11):2587-98. DOI: 10.1016/j.micinf.2006.07.007. View

4.
Tesfa L, Koch F, Pankow W, Volk H, Kern F . Confirmation of Mycobacterium tuberculosis infection by flow cytometry after ex vivo incubation of peripheral blood T cells with an ESAT-6-derived peptide pool. Cytometry B Clin Cytom. 2004; 60(1):47-53. DOI: 10.1002/cyto.b.20007. View

5.
Zenclussen A, Hammerling G . Cellular Regulation of the Uterine Microenvironment That Enables Embryo Implantation. Front Immunol. 2015; 6:321. PMC: 4470084. DOI: 10.3389/fimmu.2015.00321. View